Omicron (B.1.1.529) variant: Development, dissemination, and dominance.
作者信息
Rahmani Shayan, Rezaei Nima
机构信息
Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
出版信息
J Med Virol. 2022 May;94(5):1787-1788. doi: 10.1002/jmv.27563. Epub 2022 Jan 7.
Abstract
摘要
相似文献
1
Omicron (B.1.1.529) variant: Development, dissemination, and dominance.奥密克戎（B.1.1.529）变种：演变、传播及主导地位
J Med Virol. 2022 May;94(5):1787-1788. doi: 10.1002/jmv.27563. Epub 2022 Jan 7.
2
Characteristics and outcomes of COVID-19 patients during B.1.1.529 (Omicron) dominance compared to B.1.617.2 (Delta) in 89 German hospitals.89 家德国医院中 B.1.1.529（奥密克戎）优势期与 B.1.617.2（德尔塔）相比 COVID-19 患者的特征和结局。
BMC Infect Dis. 2022 Oct 27;22(1):802. doi: 10.1186/s12879-022-07781-w.
3
Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.疫苗对 Alpha、Delta 或奥密克戎变异株流行期间 SARS-CoV-2 再感染的有效性：一项丹麦全国性研究。
PLoS Med. 2022 Nov 22;19(11):e1004037. doi: 10.1371/journal.pmed.1004037. eCollection 2022 Nov.
4
Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.2021 年 7 月 15 日至 9 月 23 日和 2021 年 12 月 21 日至 2022 年 1 月 27 日期间，加利福尼亚州一家医院因实验室确诊的 SARS-CoV-2 感染住院的成年人的临床特征和结局，期间 B.1.617.2（德尔塔）和 B.1.1.529（奥密克戎）变异株占主导地位。
MMWR Morb Mortal Wkly Rep. 2022 Feb 11;71(6):217-223. doi: 10.15585/mmwr.mm7106e2.
5
Editorial: The 2022 World Health Organization (WHO) Priority Recommendations and Response to the Omicron Variant (B.1.1.529) of SARS-CoV-2.社论：2022 年世界卫生组织（WHO）关于 SARS-CoV-2 奥密克戎变异株（B.1.1.529）的优先推荐意见和应对措施。
Med Sci Monit. 2022 Feb 1;28:e936199. doi: 10.12659/MSM.936199.
6
PCR performance in the SARS-CoV-2 Omicron variant of concern?新冠病毒奥密克戎变异株中的 PCR 性能如何？
Swiss Med Wkly. 2021 Dec 10;151:w30120. doi: 10.4414/smw.2021.w30120. eCollection 2021 Dec 6.
7
TMPRSS2 Is Essential for SARS-CoV-2 Beta and Omicron Infection.TMPRSS2 对于 SARS-CoV-2 Beta 和奥密克戎变异株感染是必需的。
Viruses. 2023 Jan 18;15(2):271. doi: 10.3390/v15020271.
8
Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8 T-Cell Epitopes Identified in COVID-19 Convalescent Individuals.在 COVID-19 康复个体中鉴定的与 SARS-CoV-2 的奥密克戎变异株相关的突变和 CD8 T 细胞表位之间最小交叉。
mBio. 2022 Apr 26;13(2):e0361721. doi: 10.1128/mbio.03617-21. Epub 2022 Mar 1.
9
Comparison of risk factors for SARS-CoV-2 infection among healthcare workers during Omicron and Delta dominance periods in Japan.比较日本奥密克戎和德尔塔变异株流行期间医护人员感染 SARS-CoV-2 的危险因素。
J Hosp Infect. 2023 Apr;134:97-107. doi: 10.1016/j.jhin.2023.01.018. Epub 2023 Feb 16.
10
Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.疫苗对 Alpha、Delta 或奥密克戎变异株引起的 SARS-CoV-2 感染或 COVID-19 住院的有效性：一项全国性丹麦队列研究。
PLoS Med. 2022 Sep 1;19(9):e1003992. doi: 10.1371/journal.pmed.1003992. eCollection 2022 Sep.
引用本文的文献
1
Differences in Clinical Presentation of COVID-19 in Children Hospitalized During Domination of Early (BA.1, BA.2) and Late (BA.5, BA.2.75, BQ.1 and XBB.1.5) SARS-CoV-2 Omicron Subvariants.奥密克戎变异株早期（BA.1、BA.2）和晚期（BA.5、BA.2.75、BQ.1 和 XBB.1.5）流行期间住院儿童 COVID-19 临床表现的差异。
Pediatr Infect Dis J. 2024 Feb 1;43(2):149-154. doi: 10.1097/INF.0000000000004167. Epub 2023 Nov 3.
2
Unraveling the Dynamics of Omicron (BA.1, BA.2, and BA.5) Waves and Emergence of the Deltacton Variant: Genomic Epidemiology of the SARS-CoV-2 Epidemic in Cyprus (Oct 2021-Oct 2022).解析奥密克戎（BA.1、BA.2 和 BA.5）波动态及德尔塔克戎变异株出现：塞浦路斯 2021 年 10 月至 2022 年 10 月期间 SARS-CoV-2 流行的基因组流行病学。
Viruses. 2023 Sep 15;15(9):1933. doi: 10.3390/v15091933.
3
Real-world experience of arbidol for Omicron variant of SARS-CoV-2.阿比朵尔治疗新型冠状病毒奥密克戎变异株的真实世界经验。
J Thorac Dis. 2023 Feb 28;15(2):452-461. doi: 10.21037/jtd-22-980. Epub 2023 Feb 5.
4
Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies.全球新兴的 SARS-CoV-2 奥密克戎变异株：影响、挑战与策略。
J Infect Public Health. 2023 Jan;16(1):4-14. doi: 10.1016/j.jiph.2022.11.024. Epub 2022 Nov 19.
5
A model simulation on the SARS-CoV-2 Omicron variant containment in Beijing, China.中国北京针对严重急性呼吸综合征冠状病毒2奥密克戎变异株防控的模型模拟。
Intell Med. 2023 Feb;3(1):10-15. doi: 10.1016/j.imed.2022.10.005. Epub 2022 Nov 21.
6
Lancemaside A from Codonopsis lanceolata: Studies on Antiviral Activity and Mechanism of Action against SARS-CoV-2 and Its Variants of Concern.党参 Lancemaside A：抗 SARS-CoV-2 及其关注变异株的抗病毒活性和作用机制研究。
Antimicrob Agents Chemother. 2022 Dec 20;66(12):e0120122. doi: 10.1128/aac.01201-22. Epub 2022 Nov 14.
7
Clinical course of COVID-19 in hospitalized children of Ukraine in different pandemic periods.乌克兰不同疫情时期住院儿童的新冠病毒病临床病程
Eur Clin Respir J. 2022 Oct 30;9(1):2139890. doi: 10.1080/20018525.2022.2139890. eCollection 2022.
8
A Systematic Review on the Emergence of Omicron Variant and Recent Advancement in Therapies.关于奥密克戎变异株的出现及近期治疗进展的系统综述
Vaccines (Basel). 2022 Sep 5;10(9):1468. doi: 10.3390/vaccines10091468.
9
Recapping the Features of SARS-CoV-2 and Its Main Variants: Status and Future Paths.概述严重急性呼吸综合征冠状病毒2（SARS-CoV-2）及其主要变体的特征：现状与未来发展路径
J Pers Med. 2022 Jun 18;12(6):995. doi: 10.3390/jpm12060995.
10
OMICRON: Virology, immunopathogenesis, and laboratory diagnosis.奥密克戎：病毒学、免疫发病机制和实验室诊断。
J Gene Med. 2022 Jul;24(7):e3435. doi: 10.1002/jgm.3435. Epub 2022 Jun 30.
本文引用的文献
1
Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa.南非出现奥密克戎后，SARS-CoV-2 再感染的风险增加。
Science. 2022 May 6;376(6593):eabn4947. doi: 10.1126/science.abn4947.
2
SARS-CoV-2 Omicron strain exhibits potent capabilities for immune evasion and viral entrance.严重急性呼吸综合征冠状病毒2型奥密克戎毒株表现出强大的免疫逃逸和病毒入侵能力。
Signal Transduct Target Ther. 2021 Dec 17;6(1):430. doi: 10.1038/s41392-021-00852-5.
3
The electrostatic potential of the Omicron variant spike is higher than in Delta and Delta-plus variants: A hint to higher transmissibility?奥密克戎变异株刺突蛋白的静电势高于德尔塔和德尔塔plus变异株：这是其更高传播性的一个线索？
J Med Virol. 2022 Apr;94(4):1277-1280. doi: 10.1002/jmv.27528. Epub 2021 Dec 27.
4
Detection of highly muted coronavirus variant Omicron (B.1.1.529) is triggering the alarm for South Asian countries: Associated risk factors and preventive actions.高突变新冠病毒变异株奥密克戎（B.1.1.529）的检测正在引发南亚国家的警觉：相关风险因素及预防措施。
J Med Virol. 2022 Apr;94(4):1267-1268. doi: 10.1002/jmv.27503. Epub 2021 Dec 8.
5
Where did 'weird' Omicron come from?“诡异”的奥密克戎毒株源自何处？
Science. 2021 Dec 3;374(6572):1179. doi: 10.1126/science.acx9738. Epub 2021 Dec 2.
6
Omicron variant (B.1.1.529) of SARS-CoV-2, a global urgent public health alert!严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的奥密克戎变异株（B.1.1.529），全球紧急公共卫生警报！
J Med Virol. 2022 Apr;94(4):1255-1256. doi: 10.1002/jmv.27491. Epub 2021 Dec 7.
7
The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus.与原始的 SARS-CoV-2 病毒相比，SARS-CoV-2 的 Delta 变体的繁殖数要高得多。
J Travel Med. 2021 Oct 11;28(7). doi: 10.1093/jtm/taab124.
Zotero 插件